CCRN · Cross Country Healthcare Inc
Price & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Revenue per day filled | $2,240 | Q1 2026 | — |
|
|
|||
| Revenue per FTE per day | $351 | Q1 2026 | — |
|
|
|||
| Total days filled | 17,688 | Q1 2026 | — |
|
|
|||
| Unrestricted shares outstanding | 31.2M | Q1 2026 | — |
| Borrowing base availability under the ABL | $114.6M | As of December 31, 2025 | — |
| Intellify® facilities | 735 | Full Year 2025 | — |
| Intellify® hours processed | 5.7M | Full Year 2025 | — |
| Intellify® users | 5,900 | Full Year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CCRN
this stock
Cross Country Healthcare Inc
|
$428.08M | +63.5% | -5.6% | — | 2.7% |
|
HCA
HCA Healthcare, Inc.
|
$82.34B | -20.4% | +7.1% | 12.8 | 2.4% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$27.01B | -16.3% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$16.79B | -1.9% | -2.3% | 10.1 | 4.3% |
|
DVA
Davita Inc.
|
$15.21B | +108.6% | +6.5% | 22.1 | 7.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CCRN | +0.2% | +0.5% | +46.8% | +0.2% | +63.5% |
| SPY | -1.5% | +0.3% | +7.8% | -0.5% | +9.0% |
| vs SPY | +1.7% | +0.2% | +38.9% | +0.7% | +54.5% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.